1. Home
  2. SGMA vs LPCN Comparison

SGMA vs LPCN Comparison

Compare SGMA & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMA
  • LPCN
  • Stock Information
  • Founded
  • SGMA 1993
  • LPCN 1997
  • Country
  • SGMA United States
  • LPCN United States
  • Employees
  • SGMA 2750
  • LPCN N/A
  • Industry
  • SGMA Electrical Products
  • LPCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGMA Technology
  • LPCN Health Care
  • Exchange
  • SGMA Nasdaq
  • LPCN Nasdaq
  • Market Cap
  • SGMA 18.4M
  • LPCN 16.1M
  • IPO Year
  • SGMA 1994
  • LPCN N/A
  • Fundamental
  • Price
  • SGMA $3.01
  • LPCN $3.44
  • Analyst Decision
  • SGMA
  • LPCN Strong Buy
  • Analyst Count
  • SGMA 0
  • LPCN 2
  • Target Price
  • SGMA N/A
  • LPCN $9.00
  • AVG Volume (30 Days)
  • SGMA 64.7K
  • LPCN 41.8K
  • Earning Date
  • SGMA 09-18-2025
  • LPCN 08-07-2025
  • Dividend Yield
  • SGMA N/A
  • LPCN N/A
  • EPS Growth
  • SGMA N/A
  • LPCN N/A
  • EPS
  • SGMA N/A
  • LPCN N/A
  • Revenue
  • SGMA $311,706,094.00
  • LPCN $3,674,834.00
  • Revenue This Year
  • SGMA N/A
  • LPCN N/A
  • Revenue Next Year
  • SGMA N/A
  • LPCN N/A
  • P/E Ratio
  • SGMA N/A
  • LPCN N/A
  • Revenue Growth
  • SGMA N/A
  • LPCN N/A
  • 52 Week Low
  • SGMA $0.96
  • LPCN $2.68
  • 52 Week High
  • SGMA $5.12
  • LPCN $6.17
  • Technical
  • Relative Strength Index (RSI)
  • SGMA 69.93
  • LPCN 60.97
  • Support Level
  • SGMA $2.92
  • LPCN $3.10
  • Resistance Level
  • SGMA $3.00
  • LPCN $3.27
  • Average True Range (ATR)
  • SGMA 0.01
  • LPCN 0.20
  • MACD
  • SGMA -0.02
  • LPCN 0.03
  • Stochastic Oscillator
  • SGMA 80.00
  • LPCN 73.33

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: